Wells Fargo analyst Mohit Bansal assigned a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target of ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

Independence Bank of Kentucky boosted its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 3.5% during the second quarter, according to the company in its most recent ...

Eli Lilly and Company Stock Up 0.0 % Shares of NYSE:LLY opened at $924.05 on Tuesday. The company has a quick ratio of 0.87, a current ratio of 1.11 and a debt-to-equity ratio of 1.74. The company ...

An analysis of Eli Lilly's stock reveals high premium, overvaluation concerns and a low dividend yield. LLY is rated hold due ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... We plan to trade around the ranges." MS also shares key details for the unemployment rate, which are important ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring ...

With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

We recently published a list of 10 Stocks That May Be Splitting Soon. In this article, we are going to take a look at where ...